Deprescribing: Clinical Trials

19 trials for Deprescribing, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 3 recruiting, 2 active not recruiting, 2 unknown. 15 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable15Completed 6, Active not recruiting 2, Recruiting 2, Unknown 2, Enrolling by invitation 1, Not yet recruiting 1, Withdrawn 1

Follow Deprescribing: new trials by email Literature Review of Deprescribing trials Research Report on Deprescribing

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testing the Impact of Pre-visit Priming for Medications
Pre-visit prompts - Deprescribing, Statin Prescribing
Not applicableEnrolling by invitationBrigham and Women's Hospital17002026-06-102026-10-13
General Practitioner & Pharmacist Support for Discontinuing Long-term Antidepressants in Clinically Stable Patients
GPS-AD intervention - Deprescribing, Antidepressant
Not applicableNot yet recruitingUniversity Ghent3242026-03-012026-02-09
Deprescribing in Outpatient Internal Medicine Practices
medication review - Deprescribing
Not applicableCompletedWake Forest University Health Sciences262025-11-122026-07-06
Population Health Approach to Optimizing Medications in Older Adults
Patient-tailored deprescribing assessment and intervention - Medication Adverse Effects, Older Adults (65 Years and Older)
Not applicableActive not recruitingCedars-Sinai Medical Center1002025-05-192026-03-27
Co-development of a Deprescribing Program for Older Community-dwelling Patients Treated With Anticholinergic/Sedative Medications
Focus groups and workshops of healthcare professionals and patients - Deprescribing
CompletedHospices Civils de Lyon352025-04-282026-06-26
RAK-PRIDE: Optimizing Proton Pump Inhibitor Use Through Education and Intervention
Control (Standard treatment), Pharmacist-Led Educational Intervention - Proton Pump Inhibitors, Deprescribing
Not applicableRecruitingRAK Medical and Health Sciences University4792025-03-012025-03-12
Leveraging Behavioral Science to Improve Medicine Optimization Conversations With Older Adults
Anticipated long-term use of medication, Period re-evaluation of medication - Deprescribing
Not applicableCompletedUniversity of Michigan24202024-11-012025-09-26
Prevalence of Inappropriate Prescriptions and Omitted Therapies in Hospitalized Elderly: STOPP/START Criteria Analysis
medication review and deprescribing - Polypharmacy (People Under Treatment With 5 or More Drugs), Elderly (People Aged 65 or More)
CompletedRegione del Veneto - AULSS n. 7 Pedemontana1002024-07-172025-10-02
DEprescribing: Perceptions of PAtients Living With Advanced Cancer
Semi-directed individual interviews, The self-administered questionnaires, rPATD and BMQ, The self-administered FCCHL (Functional, Communicative and Critical Health Literacy) / HLS14 (14-item health literacy scale) - Deprescribing, Palliative Care
RecruitingNantes University Hospital3252024-02-282026-09-25
Deprescribing dRrugs for Overactive Bladder in General Practice (DROP)
deprescribing-intervention - Overactive Bladder, Deprescribing
Not applicableActive not recruitingAnne Estrup Olesen722023-12-012025-12-02
Effectiveness of a Joint General Practitioner-Pharmacist Intervention on Benzodiazepine Deprescribing in the Elderly
GP - pharmacist collaboration and pharmacist motivational interviewing - Primary Care, Health Plan Implementation
Not applicableRecruitingNantes University Hospital4002023-10-162026-06-24
Shared Decision Making About Medication Use for People With Multiple Health Problems
Educational Materials - Polypharmacy, Dementia
Not applicableCompletedJohns Hopkins University222023-05-222024-11-27
Testing the SNOWDROP Intervention: Using a Clinical Decision Support System and Patient Portal for Falls Prevention Among Older Patients in Primary Care
CDSS, Patient Portal - Fall, Fall Injury
Not applicableCompletedUniversity of Amsterdam852022-11-212024-01-10
Spread and Scale of a Polypharmacy App
MedReviewRx - Polypharmacy, Deprescribing
Not applicableUnknownCentre for Innovation and Research in Aging, Canada10002021-08-012021-06-16
MedSafer E-care: an Automated Deprescribing Solution (E-CARE Study)
Electronic decision support for deprescribing (MedSafer tool) - Polypharmacy, Deprescribing
Not applicableWithdrawnMcGill University Health Centre/Research Institute of the McGill University Health Centre2021-01-012023-11-02
Effect of Medication Management at Home Via Pharmacy Home Televisits
Medication management via televisit to home - Polypharmacy, Deprescribing
Not applicableCompletedVA Office of Research and Development3042020-07-162026-01-08
Reducing Costs by Deprescribing Medications
Deprescribing Intervention, Usual Care - Polypharmacy, Deprescribing
Not applicableCompletedThe University of Texas Health Science Center, Houston4192019-12-092022-11-22
Efficacy and Feasibility of De-prescribing Rounds in a Singapore Rehabilitative Hospital- a Pilot Randomized Controlled Trial
Weekly MDT deprescribing rounds for certain drugs - Deprescribing, Multi-disciplinary
Not applicableUnknownBright Vision Hospital2602018-11-282020-05-20
How do Older Adults and Caregivers Feel About Their Medications?
rPATD Questionnaire - Deprescribing
CompletedMonash University10572017-07-252018-04-04

Narrower conditions

Drug-Related Side Effects and Adverse Reactions (4)  ·  Multiple Chronic Conditions (2)  ·  Anxiety Disorders (1)  ·  Cognitive Dysfunction (1)  ·  Dementia (1)  ·  Depression (1)  ·  Neoplasms (1)  ·  Peptic Ulcer (1)  ·  Urinary Bladder, Overactive (1)

Broader conditions

Chemically-Induced Disorders (4)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Chronic Disease (2)  ·  Disease Attributes (2)  ·  Mental Disorders (2)  ·  Pathologic Processes (2)  ·  Behavior (1)  ·  Behavioral Symptoms (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cognition Disorders (1)  ·  Digestive System Diseases (1)  ·  Duodenal Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)

Interventions

Deprescriptions (2)  ·  Medication Review (2)  ·  Focus Groups (1)  ·  Functional Status (1)  ·  Methods (1)  ·  Patient Portals (1)

Sponsors

Nantes University Hospital (2)  ·  Anne Estrup Olesen (1)  ·  Brigham and Women's Hospital (1)  ·  Bright Vision Hospital (1)  ·  Cedars-Sinai Medical Center (1)  ·  Centre for Innovation and Research in Aging, Canada (1)  ·  Hospices Civils de Lyon (1)  ·  Johns Hopkins University (1)  ·  McGill University Health Centre/Research Institute of the McGill University Health Centre (1)  ·  Monash University (1)  ·  RAK Medical and Health Sciences University (1)  ·  Regione del Veneto - AULSS n. 7 Pedemontana (1)  ·  The University of Texas Health Science Center, Houston (1)  ·  University Ghent (1)  ·  University of Amsterdam (1)

Countries

United States (7)  ·  France (3)  ·  Canada (2)  ·  Singapore (2)  ·  Denmark (1)  ·  Italy (1)  ·  Netherlands (1)  ·  United Arab Emirates (1)

Top investigators

Anne E Olesen, Professor (1)  ·  Ariel Green, MD, MPH, PhD (1)  ·  Arwa Alnahdi (1)  ·  Carole Goodine, Pharm D (1)  ·  Ellen Van Leeuwen, MD, PhD (1)  ·  Emily McDonald, MD (1)  ·  Emily McDonald, MDCM (1)  ·  Holly M Holmes, MD,MS (1)  ·  Imran Rashid Rangraze (1)  ·  Julia C.M. van Weert (1)  ·  Julia Clements, PharmD (1)  ·  Lauren Rachel Moo, MD (1)  ·  Luca Pellizzari Dr. Pellizzari, DR (1)

Results publications

PMID 11298072, PMID 14687321, PMID 25183716, PMID 25385826, PMID 25798575, PMID 34674645, PMID 34727956, PMID 37711743, PMID 37960887, PMID 39042875, PMID 39163415, PMID 39908544, PMID 40445620, PMID 40767505

NIH funding

K01AG076865 (1), K23AG054742 (1), P30AG024968 (1)